California State Teachers Retirement System 13F: Cuts BSX Stake by $2.5M
CalSTRS trims its position in Boston Scientific, reducing shares and value amid a stable market outlook.
Reviewed by automated data checks against the source filing. How we make and check alerts
California State Teachers Retirement System sold 57,751 shares from its stake in Boston Scientific Corporation ($BSX), a 2.45% decrease, according to a 13F filing with the SEC dated May 18, 2026. It reported 2,299,954 shares worth $97.99 million at the end of the quarter.
Since the filing, $BSX is up 3.1% after 1 week, down 19.6% after 1 month and down 20.6% to date (from the $55.92 close on May 18, 2026).
Find the original: California State Teachers Retirement System 13F filings on SEC EDGAR
BSX
Boston Scientific Corporation
Key Points
- California State Teachers Retirement System trimmed its stake in Boston Scientific Corporation (BSX) by 57,751 shares, a reduction of 2.45%, leaving it with 2,299,954 shares valued at about $98 million as of May 18, 2026.
- Boston Scientific is currently trading at $42.60, which is close to its 52-week low of $41.39, indicating a potential opportunity for future gains.
- Analysts maintain a generally positive outlook on Boston Scientific, with a consensus recommendation of 'Buy' and a mean price target set at $59.24.
Get $BSX trade alerts by text
We text you when insiders, Congress or big funds trade $BSX. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Boston Scientific Corporation alert may contain errors. Disclosures
CalSTRS Reduces Boston Scientific Stake
California State Teachers Retirement System trimmed its stake in Boston Scientific Corporation (BSX) by 57,751 shares, a 2.45% decrease. This leaves the fund with 2,299,954 shares valued at approximately $98 million as of its latest Form 13F filing for the period ending on May 18, 2026.
Institutional Activity
No other funds reported changes in their positions for Boston Scientific during this filing period, so CalSTRS's adjustments stand out as the only major movement in this space.
How Boston Scientific Corporation Stock Has Traded
Boston Scientific shares are currently trading at $42.60, just above their 52-week low of $41.39. This price point may present opportunities for investors as the stock has room to recover toward its higher ranges, especially given its previous highs around $105.65.
Analysts Set New Price Targets
On October 14, 2026, Truist Securities maintained a 'Buy' rating on Boston Scientific with a price target of $51. Barclays initiated coverage with an 'Equal-Weight' rating and a target of $48 on October 7, 2026. Citigroup maintained a 'Neutral' rating with a price target of $48, while Wells Fargo reiterated an 'Equal-Weight' rating with the same target. Overall, analysts show a consensus recommendation of 'Buy' with a target mean price of $59.24.
What Boston Scientific Corporation Does
Boston Scientific develops and markets medical devices used in various medical specialties worldwide. The company focuses on improving patient outcomes through innovative technologies in areas like cardiology, urology, and gastrointestinal health.
What's Ahead for Boston Scientific Corporation
Investors will want to monitor Boston Scientific's performance as it approaches its next earnings report scheduled for October 28, 2026. This filing reflects holdings as of May 18, 2026, and may not represent the current position of the California State Teachers Retirement System.
Related Filing Alerts
Source: California State Teachers Retirement System's 13F filing on $BSX (May 18, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: California State Teachers Retirement System 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts